Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

SELL
$0.17 - $1.57 $107,269 - $990,662
-630,995 Reduced 42.88%
840,577 $151,000
Q4 2022

Feb 14, 2023

SELL
$1.44 - $48.2 $319,799 - $10.7 Million
-222,083 Reduced 13.11%
1,471,572 $2.37 Million
Q3 2022

Nov 14, 2022

SELL
$1.86 - $41.8 $671,718 - $15.1 Million
-361,139 Reduced 17.58%
1,693,655 $3.54 Million
Q2 2022

Aug 15, 2022

BUY
$1.46 - $3.55 $3 Million - $7.29 Million
2,054,794 New
2,054,794 $4.34 Million

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.